Cited by 129Pharmaceutical Practices and Patient OutcomesHeart Failure Treatment and ManagementPharmacy and Medical Practices

The Effectiveness of Collaborative Medicine Reviews in Delaying Time to Next Hospitalization for Patients With Heart Failure in the Practice Setting: Results of a Cohort Study

Open access
Roughead, Elizabeth E., Barratt, John D., Ramsay, Emmae, Pratt, Nicole, Ryan, Philip, Peck, Robert, Killer, Graeme, Gilbert, Andrew L.·2009·Circulation: Heart Failure

Abstract

Background— Randomized controlled trials have demonstrated that collaborative medication reviews can improve outcomes for patients with heart failure. We aimed to determine whether these results translated into Australian practice, where collaborative reviews are nationally funded. Methods and Results— This retrospective cohort study using administrative claims data included veterans 65 years and older receiving bisoprolol, carvedilol, or metoprolol succinate for which prescribing physicians indicated treatment was for heart failure. We compared those exposed to a general practitioner–pharmacist collaborative home medication review with those who did not receive the service. The service includes physician referral, a home visit by an accredited pharmacist to identify medication-related problems, and a pharmacist report with follow-up undertaken by the physician. Kaplan-Meier analyses and Cox proportional hazards models were used to compare time until next hospitalization for heart failure between the exposed and unexposed groups. There were 273 veterans exposed to a home medicines review and 5444 unexposed patients. Average age in both groups was 81.6 years (no significant difference). The median number of comorbidities was 8 in the exposed group and 7 in the unexposed ( P <0.0001). Unadjusted results showed a 37% reduction in rate of hospitalization for heart failure at any time (hazard ratio, 0.63; 95% CI, 0.44 to 0.89). Adjusted results showed a 45% reduction (hazard ratio, 0.55; 95% CI, 0.39 to 0.77) among those who had received a home medicines review compared with the unexposed patients. Conclusion— Medicines review in the practice setting is effective in delaying time to next hospitalization for heart failure in those treated with heart failure medicines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.109.861013

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Research evaluating the impact of collaborative medication reviews indicates that such services improve prescribing, and have the potential to reduce health service use and medication costs for patients with multiple chronic conditions.

    “Research evaluating the impact of collaborative medication reviews indicates that such services improve prescribing, and have the potential to reduce health service use and medication costs for patients with multiple chronic conditions [18,19].”

    From From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management (2015) · cites this paper as [19]

    The Discussion reports that collaborative home medication reviews were associated with a 45% lower rate of heart-failure hospitalization in the study population, supporting the potential to reduce health-service use. The paper describes identifying medication-related problems, but does not report improved prescribing or reduced medication costs. Its findings concern older patients with heart failure, not patients with multiple chronic conditions generally. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 16 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Pharmacy Guild of Australia. Medication management review program. Canberra, Australia: Pharmacy Guild of Australia, 2009. Available at: http://www.guild.org.au/mmr/. Accessed June 12, 2009.
  2. Vitry A, Wong S, Roughead EE, Ramsay E, Barratt J. Validity of medication-based comorbidity indices in the Australian elderly popu- lation. Aust NZ J Public Health 2009;33:126 -130.

Cited by

Sorted by citations

Authors
Roughead, E. E., Barratt, J. D., Ramsay, E., Pratt, N., Ryan, P., Peck, R., Killer, G., & Gilbert, A. L.
Affiliations
University of South Australia (AU)
Venue
Circulation: Heart Failure
Published
2009-09
Volume
2
Issue
5
Pages
424-428
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2108369890
Cited by
129
References
16
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2022: 3 · 2021: 3 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 4 · 2016: 12 · 2015: 9 · 2014: 9 · 2013: 8 · 2012: 18
FWCI
10.67
Type
journal article
Language
en
Open access
Locations
  • Circulation Heart Failure (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
Keywords
heart failure, home medicines review, pharmacist intervention, heart failure hospitalization, veterans, older adults, beta-blockers, bisoprolol, carvedilol, metoprolol succinate, drug-related problems, real-world effectiveness
MeSH terms
Carvedilol, Adrenergic beta-Antagonists, Aged, Aged, 80 and over, Australia, Carbazoles, Community Pharmacy Services, Cooperative Behavior, Family Practice, Female, Heart Failure, Hospitalization, House Calls, Humans, Male, Metoprolol, Propanolamines, Referral and Consultation, Retrospective Studies, Time Factors, Veterans, Program Evaluation, Proportional Hazards Models, Treatment Outcome, Bisoprolol, Widowhood, Risk Assessment, Databases as Topic, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review